Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions

Nicole K. Ruddock, Shao Qing Shi, Sangeeta Jain, Gradie Moore, Gary Hankins, Roberto Romero, Robert E. Garfield

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Objective: The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action. Study Design: Myometrial tissues were suspended in organ chambers and exposed for 2 to 20 hours to varying concentrations of P4 or 17P or solvent. Contractile activity was registered, stored, and analyzed. Dose response curves were then generated for P4 or 17P at various times. Results: P4 significantly inhibited spontaneous contractility dose dependently. The inhibition was not blocked by RU486 but was reversible after washing. Surprisingly, 17P dose dependently stimulated contractility. HPLC and GC-MS methods were used to determine the detectable concentrations of progestins in the baths. Conclusion: P4, at concentrations equivalent to those present in the placenta and uterus, inhibit spontaneous myometrial contractility in vitro by nongenomic mechanisms.

Original languageEnglish (US)
JournalAmerican Journal of Obstetrics and Gynecology
Volume199
Issue number4
DOIs
StatePublished - Oct 2008

Fingerprint

Uterine Contraction
Progesterone
Progestins
Baths
Placenta
Uterus
High Pressure Liquid Chromatography
In Vitro Techniques
17-alpha-hydroxy-progesterone caproate

Keywords

  • 17-alpha-hydroxyprogesterone caproate
  • myometrium
  • preterm labor
  • progesterone
  • uterine contractility

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Cite this

Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. / Ruddock, Nicole K.; Shi, Shao Qing; Jain, Sangeeta; Moore, Gradie; Hankins, Gary; Romero, Roberto; Garfield, Robert E.

In: American Journal of Obstetrics and Gynecology, Vol. 199, No. 4, 10.2008.

Research output: Contribution to journalArticle

Ruddock, Nicole K. ; Shi, Shao Qing ; Jain, Sangeeta ; Moore, Gradie ; Hankins, Gary ; Romero, Roberto ; Garfield, Robert E. / Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions. In: American Journal of Obstetrics and Gynecology. 2008 ; Vol. 199, No. 4.
@article{eaca3836b20f417cb2f7b6f3f79b7350,
title = "Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions",
abstract = "Objective: The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action. Study Design: Myometrial tissues were suspended in organ chambers and exposed for 2 to 20 hours to varying concentrations of P4 or 17P or solvent. Contractile activity was registered, stored, and analyzed. Dose response curves were then generated for P4 or 17P at various times. Results: P4 significantly inhibited spontaneous contractility dose dependently. The inhibition was not blocked by RU486 but was reversible after washing. Surprisingly, 17P dose dependently stimulated contractility. HPLC and GC-MS methods were used to determine the detectable concentrations of progestins in the baths. Conclusion: P4, at concentrations equivalent to those present in the placenta and uterus, inhibit spontaneous myometrial contractility in vitro by nongenomic mechanisms.",
keywords = "17-alpha-hydroxyprogesterone caproate, myometrium, preterm labor, progesterone, uterine contractility",
author = "Ruddock, {Nicole K.} and Shi, {Shao Qing} and Sangeeta Jain and Gradie Moore and Gary Hankins and Roberto Romero and Garfield, {Robert E.}",
year = "2008",
month = "10",
doi = "10.1016/j.ajog.2008.06.085",
language = "English (US)",
volume = "199",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Progesterone, but not 17-alpha-hydroxyprogesterone caproate, inhibits human myometrial contractions

AU - Ruddock, Nicole K.

AU - Shi, Shao Qing

AU - Jain, Sangeeta

AU - Moore, Gradie

AU - Hankins, Gary

AU - Romero, Roberto

AU - Garfield, Robert E.

PY - 2008/10

Y1 - 2008/10

N2 - Objective: The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action. Study Design: Myometrial tissues were suspended in organ chambers and exposed for 2 to 20 hours to varying concentrations of P4 or 17P or solvent. Contractile activity was registered, stored, and analyzed. Dose response curves were then generated for P4 or 17P at various times. Results: P4 significantly inhibited spontaneous contractility dose dependently. The inhibition was not blocked by RU486 but was reversible after washing. Surprisingly, 17P dose dependently stimulated contractility. HPLC and GC-MS methods were used to determine the detectable concentrations of progestins in the baths. Conclusion: P4, at concentrations equivalent to those present in the placenta and uterus, inhibit spontaneous myometrial contractility in vitro by nongenomic mechanisms.

AB - Objective: The aim was to determine whether progesterone (P4) or 17-alpha-hydroxyprogesterone caproate (17P) directly inhibit human uterine contractility in vitro and thereby clarify their mechanisms of action. Study Design: Myometrial tissues were suspended in organ chambers and exposed for 2 to 20 hours to varying concentrations of P4 or 17P or solvent. Contractile activity was registered, stored, and analyzed. Dose response curves were then generated for P4 or 17P at various times. Results: P4 significantly inhibited spontaneous contractility dose dependently. The inhibition was not blocked by RU486 but was reversible after washing. Surprisingly, 17P dose dependently stimulated contractility. HPLC and GC-MS methods were used to determine the detectable concentrations of progestins in the baths. Conclusion: P4, at concentrations equivalent to those present in the placenta and uterus, inhibit spontaneous myometrial contractility in vitro by nongenomic mechanisms.

KW - 17-alpha-hydroxyprogesterone caproate

KW - myometrium

KW - preterm labor

KW - progesterone

KW - uterine contractility

UR - http://www.scopus.com/inward/record.url?scp=52949103357&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=52949103357&partnerID=8YFLogxK

U2 - 10.1016/j.ajog.2008.06.085

DO - 10.1016/j.ajog.2008.06.085

M3 - Article

C2 - 18928984

AN - SCOPUS:52949103357

VL - 199

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 4

ER -